Cellular Screening Center

Therapeutic Approaches: Small Molecules, Biomarkers, Antibodies, Stem Cells

Therapeutic Areas of Expertise: Cardiology, Infectious Diseases, Metabolic Disorders, Neurological Disorders, Oncology, Ophthalmology, Psychiatric Disorders, Pain, Regenerative Medicine

Center/Program Highlights:

High-throughput screening plays an important role in both the drug discovery process and in the understanding of disease mechanisms. By measuring the effect that small molecule compounds have on cellular function, we can quickly identify the compounds that have a desired effect and move these molecules forwards in the drug discovery process.

The Cellular Screening Center (CSC) provides high throughput cell and non-cell based screening for researchers throughout the Chicago area. Both small molecules and siRNA libraries are offered for such screens.

Support from the Chicago Biomedical Consortium (CBC) and the University of Chicago Biological Sciences Division enabled the creation of the CSC in 2006. The facility was established to provide state-of-the-art automation for drug discovery and disease mechanism elucidation in a cleanroom setting. Automation is present for all aspects of the screening process. The CSC has attracted a significant number of collaborations with area scientists in fields as diverse as cancer biology, diabetes and ophthalmology.

Sources of Funding: Philanthropy, Industry Partnerships, Disease Foundations, University, Revenue, Federal/State,


Institutional Affiliation(s): The University of Chicago

929 E. 57th St.
Illinois, 60637
United States

Center/Program Start Date: 2007

Number of Employees: 3